193 related articles for article (PubMed ID: 26201639)
1. Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial.
Sarin SK; Mishra SR; Sharma P; Sharma BC; Kumar A
Hepatol Int; 2013 Mar; 7(1):248-56. PubMed ID: 26201639
[TBL] [Abstract][Full Text] [Related]
2. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
Sharma P; Kumar A; Sharma BC; Sarin SK
Aliment Pharmacol Ther; 2009 Jul; 30(1):48-60. PubMed ID: 19392862
[TBL] [Abstract][Full Text] [Related]
3. 5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial.
Vukotic R; Di Donato R; Roncarati G; Simoni P; Renzulli M; Gitto S; Schepis F; Villa E; Berzigotti A; Bosch J; Andreone P
J Hepatol; 2023 Oct; 79(4):977-988. PubMed ID: 37482222
[TBL] [Abstract][Full Text] [Related]
4. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status.
Wadhawan M; Dubey S; Sharma BC; Sarin SK; Sarin SK
Dig Dis Sci; 2006 Dec; 51(12):2264-9. PubMed ID: 17080245
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial.
Mishra SR; Chander Sharma B; Kumar A; Sarin SK
Gut; 2010 Jun; 59(6):729-35. PubMed ID: 20551457
[TBL] [Abstract][Full Text] [Related]
6. Use of portal pressure studies in the management of variceal haemorrhage.
Addley J; Tham TC; Cash WJ
World J Gastrointest Endosc; 2012 Jul; 4(7):281-9. PubMed ID: 22816007
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT.
Gupta V; Rawat R; Shalimar ; Saraya A
Hepatol Int; 2017 Mar; 11(2):181-187. PubMed ID: 27624505
[TBL] [Abstract][Full Text] [Related]
8. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.
Kirnake V; Arora A; Gupta V; Sharma P; Singla V; Bansal N; Goyal M; Chawlani R; Kumar A
J Clin Exp Hepatol; 2016 Sep; 6(3):175-185. PubMed ID: 27746613
[TBL] [Abstract][Full Text] [Related]
10. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
Groszmann RJ; Garcia-Tsao G; Bosch J; Grace ND; Burroughs AK; Planas R; Escorsell A; Garcia-Pagan JC; Patch D; Matloff DS; Gao H; Makuch R;
N Engl J Med; 2005 Nov; 353(21):2254-61. PubMed ID: 16306522
[TBL] [Abstract][Full Text] [Related]
12. Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics.
Tey TT; Gogna A; Irani FG; Too CW; Lo HG; Tan BS; Tay KH; Lui HF; Chang PE
Singapore Med J; 2016 Mar; 57(3):132-7. PubMed ID: 26996384
[TBL] [Abstract][Full Text] [Related]
13. Hepatic venous pressure gradient is a useful predictor in guiding treatment on prevention of variceal rebleeding in cirrhosis.
Li GQ; Yang B; Liu J; Wang GC; Yuan HP; Zhao JR; Liu JY; Li XP; Zhang CQ
Int J Clin Exp Med; 2015; 8(10):19709-16. PubMed ID: 26770635
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J
J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy of Carvedilol in Comparison to Propranolol in Reducing the Hepatic Venous Pressure Gradient and Decreasing the Risk of Variceal Bleeding in Adult Cirrhotic Patients: A Systematic Review.
Dardari L; Taha M; Dahat P; Toriola S; Satnarine T; Zohara Z; Adelekun A; Seffah KD; Salib K; Arcia Franchini AP
Cureus; 2023 Aug; 15(8):e43253. PubMed ID: 37577269
[TBL] [Abstract][Full Text] [Related]
17. Preventing first variceal hemorrhage in cirrhosis.
Albillos A
J Clin Gastroenterol; 2007; 41 Suppl 3():S305-11. PubMed ID: 17975481
[TBL] [Abstract][Full Text] [Related]
18. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial.
Mishra SR; Sharma BC; Kumar A; Sarin SK
J Hepatol; 2011 Jun; 54(6):1161-7. PubMed ID: 21145834
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial.
Bhardwaj A; Kedarisetty CK; Vashishtha C; Bhadoria AS; Jindal A; Kumar G; Choudhary A; Shasthry SM; Maiwall R; Kumar M; Bhatia V; Sarin SK
Gut; 2017 Oct; 66(10):1838-1843. PubMed ID: 27298379
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices.
Paternostro R; Becker J; Hofer BS; Panagl V; Schiffke H; Simbrunner B; Semmler G; Schwabl P; Scheiner B; Bucsics T; Bauer D; Binter T; Trauner M; Mandorfer M; Reiberger T
Dig Liver Dis; 2022 Apr; 54(4):500-508. PubMed ID: 34799282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
